Julie Rubinstein's most recent trade in Adaptive Biotechnologies Corp was a trade of 175,000 Common Stock done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 175,000 | 647,754 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 40,044 | 607,710 (0%) | 0% | 7.0 | 279,507 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 19,461 | 588,249 (0%) | 0% | 7.0 | 136,032 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 175,000 | 511,824 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 25,580 | 486,244 (0%) | 0% | 3.4 | 87,739 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 3.56 per share. | 04 Mar 2024 | 13,490 | 472,754 (0%) | 0% | 3.6 | 48,024 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 199,549 | 199,549 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 132,979 | 359,492 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 06 Mar 2023 | 22,668 | 336,824 (0%) | 0% | 8.6 | 194,265 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 463,344 | 463,344 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 185,338 | 231,126 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 4,613 | 226,513 (0%) | 0% | 12.0 | 55,402 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 114,469 | 114,469 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 45,788 | 45,788 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 15,000 | 225,325 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 01 Mar 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 58.64 per share. | 01 Mar 2021 | 9,471 | 845 (0%) | 0% | 58.6 | 555,379 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 57.54 per share. | 01 Mar 2021 | 4,684 | 10,316 (0%) | 0% | 57.5 | 269,517 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 58.99 per share. | 01 Mar 2021 | 845 | 0 (0%) | 0% | 59.0 | 49,847 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 15,000 | 240,325 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 56.23 per share. | 26 Feb 2021 | 15,000 | 0 (0%) | 0% | 56.2 | 843,450 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 26 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 24 Feb 2021 | 15,000 | 15,000 (0%) | 0% | 6.6 | 98,250 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 15,000 | 270,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 14,675 | 255,325 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 24 Feb 2021 | 14,675 | 14,675 (0%) | 0% | 6.5 | 96,121 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 56.13 per share. | 24 Feb 2021 | 14,076 | 599 (0%) | 0% | 56.1 | 790,086 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 56.45 per share. | 24 Feb 2021 | 4,234 | 10,766 (0%) | 0% | 56.4 | 239,009 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 57.12 per share. | 24 Feb 2021 | 4,134 | 6,632 (0%) | 0% | 57.1 | 236,134 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 58.74 per share. | 24 Feb 2021 | 3,374 | 3,258 (0%) | 0% | 58.7 | 198,189 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 59.33 per share. | 24 Feb 2021 | 3,258 | 0 (0%) | 0% | 59.3 | 193,297 | Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President | Sale of securities on an exchange or to another person at price $ 57.33 per share. | 24 Feb 2021 | 599 | 0 (0%) | 0% | 57.3 | 34,341 | Common Stock |